News and Events
Daniel Chang, M.D., was named chair of the Department of Radiation Oncology at Michigan Medicine. The University of Michigan Board of Regents approved the appointment at its Sept. 22 meeting. Chang, who is currently the Sue and Bob McCollum Professor of Radiation Oncology at Stanford University, will begin at U-M on Oct. 1.
Rogel researchers have developed a new mathematical technique to begin to understand how a cell’s nucleus is organized. The technique, tested on several types of cells, revealed what the researchers termed self-sustaining transcription clusters, a subset of proteins that play a key role in maintaining cell identity. They hope this understanding will expose vulnerabilities that can be targeted to reprogram a cell to stop cancer or other diseases.
The second annual Colorful event is an evening of celebration and support of cancer research at the Rogel Cancer Center, the No. 1 ranked cancer program in Michigan. The evening will include both in-person and virtual options. Colorful will be a talk-show-style event hosted by NFL alums Dhani Jones with special guest Devon Still, and will include comments from Rogel researchers and patients.
The Rogel Cancer Center has submitted the 2022 grant renewal application for the National Cancer Institute’s Cancer Center Support Grant. Every five years, the cancer center must submit a renewal application for continued funding under the CCSG. Earlier this summer, the Rogel Cancer Center team completed and submitted the most recent CCSG renewal application.
Rogel Cancer Center named No. 1 cancer program in Michigan, among best in nation by U.S. News & World Report
The University of Michigan Rogel Cancer Center was rated the best cancer hospital in Michigan and among the best nationwide by U.S. News & World Report “Best Hospitals” rankings for 2022-2023. Rogel is the only Michigan cancer program to be ranked.